Glaucoma Progressing Despite Normal Pressure: 24 Hour IOP

Glaucoma progression despite apparently controlled intraocular pressure is one of the most disorienting experiences a patient can face. It is also one of the most common reasons patients seek a glaucoma second opinion. The reason is almost always the same: daytime clinic readings capture one moment. They do not capture what happens at night, explains Dr Shibal Bhartiya.

Not all glaucoma medications lower pressure around the clock. Brimonidine and timolol both show significantly reduced activity after midnight. A patient whose pressure is controlled at 11 am may have entirely uncontrolled pressure at 3 am — and no standard clinic visit will reveal this.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

My Glaucoma Is Progressing But My Pressure Is Always Normal. What Is Going On?

He was in his early sixties — careful, informed, and deeply confused.

He came to me for a second opinion after five to six years under glaucoma care. His file was meticulous. His lifestyle was exemplary — non-smoker, controlled blood pressure, controlled blood sugars. He was on two medications: timolol and brimonidine. His baseline IOP had been 26 to 27 mmHg. On treatment, it now sat at 13 to 14 mmHg at every clinic visit for years.

By every standard measure, he was a success story. But his glaucoma was still progressing.

He was not angry. He was bewildered. I have done everything right, he told me. Why is this still happening?

That question deserved a better answer than he had been given. The answer was in the hours nobody had measured.

The question nobody had asked

I looked at his records and asked him one thing: had anyone ever done a diurnal variation for him? A 24-hour IOP measurement, mapped across day and night? Or a Water Drinking Test?

He said no.

We enrolled him in a study using the Triggerfish sensor — a contact lens device that records continuous IOP fluctuation over 24 hours. The device does not measure absolute pressure values, but it maps the pattern of fluctuation with precision.

The night-time readings were almost double the daytime values.

Most clinic visits measure pressure once, mid-morning, when he was up and about. That is the reading least likely to catch a nocturnal spike. His reassuring numbers, always 13, always 14, had been capturing only half the story. The other half was unfolding while he slept, while no one was measuring, while his optic nerve absorbed damage that nobody anticipated.

Why his medications were failing him at night

The reason was pharmacological, and it is something worth stating clearly: brimonidine and timolol do not work at night. Their pressure-lowering effect drops sharply in the late hours. His reassuring clinic readings — always 13, always 14 — had been capturing only half the story. The other half was invisible, unfolding while he slept, while no one was measuring, while his optic nerve absorbed damage that nobody anticipated.

This is not a failure of the medications. It is a failure of the measurement system — and of the assumption that a daytime number tells the whole story.

What Doctors Often Miss

Brimonidine and timolol do not work at night. This is pharmacology, not failure — their pressure-lowering effect drops sharply in the late hours. It is a well-documented limitation that is not always communicated to patients or factored into treatment decisions.

The result is that a patient can have genuinely excellent daytime control and entirely uncontrolled nocturnal pressure simultaneously. Standard clinic visits — timed to office hours — will never detect this.

The other missed step is the diurnal variation test itself. It is one of the most underused and highest-yield investigations in glaucoma management. It is rarely ordered unless a specialist specifically suspects nocturnal IOP spikes. If your glaucoma is progressing despite apparently good readings, this investigation is worth asking for by name — and a glaucoma second opinion is always reasonable in this situation.

Why Prostaglandins Are First-Line for a Reason

We switched him to bimatoprost 0.01% — a prostaglandin analogue. Prostaglandins are the only class of glaucoma medication proven to work continuously across 24 hours. They do not lose activity at night.

That was in 2012 to 2013. He has been stable for over six years.

One molecule change. One question that had never been asked. Six years of stability that five years of treatment had never delivered.

Symptoms, Pressure Patterns, and When to Investigate

Finding	Likely Cause	When to Investigate Further
Glaucoma progressing despite good clinic IOP	Nocturnal IOP spike not captured by daytime readings	Request 24-hour diurnal variation assessment
On timolol or brimonidine, still progressing	Night-time loss of drug efficacy	Ask whether a prostaglandin has been considered
Visual field deterioration at routine review	Ongoing IOP fluctuation between clinic visits	IOP fluctuation may be as damaging as sustained elevation
Good compliance, good lifestyle, still progressing	Medication class mismatch for 24-hour coverage	Second opinion from glaucoma specialist
Pressure controlled but OCT showing RNFL thinning	Structural damage continuing despite IOP numbers	Full diurnal assessment and treatment review

What This Means for You

If your glaucoma is progressing despite readings that look controlled, the readings may be incomplete — not the whole story, only the morning chapter.

The questions worth asking at your next visit: Has my pressure ever been measured at night? Has anyone checked whether my medications work across 24 hours? Has a prostaglandin analogue been considered as my primary medication?

You are not doing anything wrong. The measurement system may simply be missing the hours that matter most.

If your glaucoma is progressing despite treatment, or if you have never had a 24-hour IOP assessment, a specialist review may give you answers years of routine care have not.

Book a consultation or second opinion with Dr Shibal Bhartiya in Gurgaon.
+91 88826 38735 | www.drshibalbhartiya.com

FAQs

My glaucoma is progressing but my eye pressure is always normal at the clinic. How is that possible?

Clinic readings capture pressure at one moment, usually mid-morning. Eye pressure fluctuates across 24 hours. Certain medications — including timolol and brimonidine — lose effectiveness at night. If pressure spikes at 2 am, no daytime clinic visit will catch it. That spike is still damaging your optic nerve, invisibly, visit after visit.

What is a diurnal variation test and do I need one?

A diurnal variation maps your eye pressure across the full day and night. It is recommended when glaucoma is progressing despite apparently controlled pressure, when you are on medications that may not provide round-the-clock coverage, or when your specialist suspects night-time IOP spikes. It is one of the most underused and highest-yield tests in glaucoma management.

Why are prostaglandin eye drops the first choice for glaucoma?

Prostaglandins are the only class of glaucoma medication that works continuously across 24 hours. Other drugs — including timolol and brimonidine — show significantly reduced activity at night. For long-term pressure control, the night-time hours matter as much as the daytime ones. This is why prostaglandin analogues are recommended as first-line therapy in international glaucoma guidelines.

Can glaucoma progress even when I am doing everything right?

Yes, and it is more common than patients realise. Controlled daytime pressure, healthy lifestyle, medication compliance — none of these guarantee protection if night-time IOP is unaddressed. Progression despite apparent control is a signal to investigate further, not to doubt yourself. A glaucoma second opinion is always reasonable in this situation.

Should I ask for a 24-hour IOP test if my glaucoma is progressing?

Yes. If your visual fields are declining despite good clinic readings, a diurnal variation assessment is a reasonable and important next step. Ask your glaucoma specialist specifically about this. It is a question worth asking at your next visit.

This page is part of the Advanced Glaucoma Care hub. Read about the full spectrum of glaucoma diagnosis and treatment. Please also read about Diurnal Variation of IOP, Target IOP and Glaucoma Eye Drops.

You may want to watch this podcast I did several years ago, for Health Talks.

Note: Contact Lens Monitor for Continuous IOP Monitoring

Triggerfish® contact lens sensor is a specialised diagnostic contact lens used in glaucoma care to monitor intraocular pressure (IOP)–related changes over 24 hours. Unlike routine pressure measurements taken during clinic hours, the Triggerfish lens (Sensimed Triggerfish) helps detect pressure fluctuations that may occur at night or outside OPD visits, which can sometimes explain progression despite apparently controlled readings. It does not measure pressure directly in mmHg but records circumferential corneal changes related to IOP patterns, helping glaucoma specialists better understand individual risk profiles and treatment needs in selected patients.

Dr Shibal Bhartiya was the first doctor in India to use the Triggerfish® contact lens sensor for Continuous IOP Monitoring in clinical practice. Her initial experiences on Intraocular pressure (IOP) related pattern in patients with primary angle closure (PAC) and primary angle closure glaucoma (PACG) before and after laser peripheral iridotomy (LPI) was presented at ARVO, in Orlando Florida in 2014

IOP Fluctuation and Angle Closure Glaucoma

IOP fluctuation is a particular concern in angle closure disease, where pressure spikes can be steep and are frequently missed by routine daytime readings. Dr Bhartiya’s published research has examined this directly. A 2015 study in the Journal of Current Glaucoma Practice, Diurnal Intraocular Pressure Fluctuation in Eyes with Angle-Closure (Bhartiya S, Ichhpujani P; PMID: 26997828), investigated IOP fluctuation across the day in 77 newly diagnosed angle closure patients and documented the range and pattern of diurnal variation in this group.

A 2019 review in the Romanian Journal of Ophthalmology, Diurnal Variation of IOP in Angle Closure Disease: Are We Doing Enough? (Bhartiya S et al.; PMID: 31687621), went further — finding that many clinical decisions in angle closure glaucoma management are based on only one or two IOP measurements, and arguing that this is insufficient given the established circadian rhythm of IOP and its direct correlation with glaucoma progression. Taken together, these papers make the case that angle closure patients may be among the most undertreated precisely because their worst pressure moments are the least observed.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (PubMed-indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks, span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1,500+ Five Star Patient Reviews — Google Business Profile

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review. | www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Can Playing Wind Instruments Affect Glaucoma?

Some wind instruments can temporarily increase pressure inside the eye during performance. For musicians with glaucoma or glaucoma risk factors, understanding how instrument type, breathing technique, and eye health interact may help protect long-term vision.

Here is what Musicians Need to Know About Eye Pressure, Technique, and Long-Term Vision, says Dr Shibal Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Dr. Shibal Bhartiya has published peer-reviewed research examining the relationship between glaucoma and musical instrument performance. The discussion in this article draws upon both published evidence and ongoing clinical interest in how lifestyle activities may influence intraocular pressure and optic nerve health.

Related publication: Eye-tunes: role of music in ophthalmology and vision sciences; Twenty four hour eye pressure monitoring

Music, Breathing, and Eye Health: An Overlooked Conversation

Most people think of glaucoma as a disease influenced by age, family history, eye pressure, and genetics. Few consider whether a lifelong hobby or profession could affect the eyes.

Yet musicians who play wind instruments generate substantial airflow and pressure during performance. Researchers have therefore explored whether playing certain instruments might temporarily increase intraocular pressure (IOP), the pressure inside the eye.

The answer is more nuanced than many headlines suggest.

While some wind instruments may be associated with transient rises in eye pressure by almost 10%, the effects vary depending on the instrument, the player, the technique used, and the individual’s underlying glaucoma risk.

Following publication, Professor Frank Gabriel Campos, Professor Emeritus of Trumpet at Ithaca College, provided valuable insights regarding brass performance technique and the distinction between efficient airflow support and Valsalva-like straining. This article has been written to reflect those nuances and to encourage a more technique-sensitive interpretation of the available evidence.

Why Eye Pressure Matters in Glaucoma

Glaucoma is a chronic optic nerve disease that often progresses silently. Elevated intraocular pressure is one of its most important risk factors.

What makes glaucoma challenging is that damage often develops gradually over years before noticeable symptoms appear.

Many patients continue to see well while subtle changes accumulate in peripheral vision, contrast sensitivity, dark adaptation, or visual processing.

This is why activities that may temporarily increase eye pressure have attracted scientific interest.

Do Wind Instruments Increase Eye Pressure?

Several studies have reported temporary increases in intraocular pressure while playing certain wind instruments.

Researchers believe this may occur because high-resistance instruments require forceful exhalation against resistance, generating pressure changes within the chest, neck, and head.

These physiological changes may influence:

Venous pressure
Blood flow dynamics
Intraocular pressure
Optic nerve perfusion

Importantly, temporary increases in eye pressure are not the same as glaucoma.

Most musicians who play wind instruments never develop glaucoma.

However, for individuals who already have glaucoma, ocular hypertension, suspicious optic nerves, or a strong family history, these findings may be clinically relevant.

Not All Instruments Are the Same

Different instruments create different airflow demands and resistance.

Instruments Often Associated with Higher Resistance

Instrument Type	Potential Eye Pressure Concern
Trumpet	Higher expiratory resistance
Oboe	Very high airflow resistance
French Horn	Sustained pressure generation
Bassoon	High resistance airflow
Certain Brass Instruments	Repeated pressure fluctuations

Instruments Generally Associated with Lower Resistance

Instrument Type	Relative Physiological Load
Flute	Lower resistance
Clarinet	Variable
Saxophone	Moderate
Recorder	Generally lower

The relationship remains complex and individual. In the Indian context, while there is little or no evidence, blowing the conch shell, and the flute may also have similar effects.

An Important Clarification About Technique

One of the most valuable insights on this topic comes not from ophthalmology, but from professional music performance.

After publication of an earlier version of this article, Professor Frank Gabriel Campos, Professor Emeritus of Trumpet at Ithaca College and author of Trumpet Technique (Oxford University Press), generously shared an important perspective.

Professor Campos notes that the Valsalva manoeuvre is generally considered poor or incorrect technique in high-level brass performance rather than a desired component of proper playing.

This distinction matters.

Some discussions of eye pressure and wind instruments assume that elevated pressure results from Valsalva-like straining. However, experienced musicians aim to support airflow efficiently without unnecessary glottic closure or excessive pressure generation.

In other words:

The physiological effects of wind instrument performance may depend not only on the instrument being played, but also on how it is played.

This highlights an important area for future research.

Understanding technique may prove just as important as understanding instrument type.

The author gratefully acknowledges Professor Frank Gabriel Campos for his thoughtful contribution to this discussion and for helping improve the accuracy and nuance of this article.

What Doctors May Miss

What Patients Think	What May Actually Be Happening
“My vision seems normal.”	Early glaucoma may cause no noticeable symptoms.
“Nobody asked about my hobbies.”	Certain activities may provide useful risk information.
“My eye pressure is normal in clinic.”	Eye pressure naturally fluctuates throughout the day.
“Playing music cannot affect my eyes.”	Some instruments may temporarily influence eye pressure.
“Only family history matters.”	Multiple risk factors interact in glaucoma development.
“If I see clearly, I must be safe.”	Functional compensation can hide early disease.

Should Musicians Stop Playing?

In most cases, no.

The purpose of understanding these findings is not to discourage music.

For many musicians, playing an instrument is a profession, passion, social connection, and lifelong source of joy.

Instead, the goal is awareness.

If you have:

Glaucoma
Ocular hypertension
A strong family history of glaucoma
Suspicious optic nerves
Progressive visual field loss

it may be worth discussing your musical activities with your eye specialist.

Monitoring can often be tailored without requiring major lifestyle changes.

Questions Worth Asking Your Eye Doctor

Does my current glaucoma appear stable?
How advanced is my disease?
Should my eye pressure be monitored more closely?
Are there activities that may affect my individual risk profile?
Do my optic nerve findings suggest increased vulnerability?
Would additional testing be useful?

This page is a part of the Glaucoma Hub. you may want to read about Glaucoma Progression, and Risk Stratification in Glaucoma.

Frequently Asked Questions

Can playing a trumpet cause glaucoma?

No. Playing a trumpet does not directly cause glaucoma. However, some studies suggest that certain wind instruments may temporarily increase eye pressure during performance.

Is it safe to play a wind instrument if I have glaucoma?

Many people with glaucoma continue playing wind instruments safely. Decisions should be individualized based on disease severity, eye pressure control, and overall risk profile.

Which instruments are most often studied?

Trumpet, oboe, bassoon, and French horn have received particular attention because of their higher airflow resistance.

Does technique matter?

Yes. Professional musicians emphasize that efficient breathing and airflow support differ from excessive straining. Technique may influence physiological responses during performance.

Can normal eye pressure readings miss risk?

Yes. Eye pressure varies throughout the day and may not always reflect pressure changes during specific activities.

Should musicians undergo glaucoma screening?

Anyone with glaucoma risk factors: including family history, elevated eye pressure, suspicious optic nerves, or age-related risk, should consider regular comprehensive eye examinations.

Can glaucoma affect musicians even if they read music normally?

Yes. Early glaucoma often affects peripheral vision first. Reading music may remain normal while subtle visual field changes develop elsewhere.

What symptoms should musicians watch for?

Glaucoma often causes no symptoms in its early stages. Regular examinations are more reliable than symptom monitoring alone.

Key Takeaway

Playing a wind instrument does not automatically mean you are at risk of glaucoma.

However, research suggests that certain instruments may temporarily increase eye pressure, particularly when substantial resistance is involved.

The relationship is complex. Instrument type, technique, breathing mechanics, eye anatomy, and individual susceptibility all matter.

For musicians with glaucoma or glaucoma risk factors, awareness—not alarm—is the right response.

The goal is not to stop making music.

The goal is to protect vision so that music can remain part of life for years to come.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Note: This article was written by Dr. Shibal Bhartiya, and was updated following correspondence with Professor Emeritus Frank Gabriel Campos regarding brass performance technique.

Why Do I Need Glaucoma Treatment If My Vision Seems Normal?

Glaucoma often causes permanent optic nerve damage long before noticeable vision loss develops. Treatment is designed to protect your future vision by slowing or preventing progression before symptoms appear, Dr Shibal Bhartiya explains.

Your vision feels fine. No pain, no blur, no obvious change. So why is your doctor urging treatment? This is the most common question glaucoma patients ask, and it deserves a direct, honest answer,

Glaucoma destroys your optic nerve silently. By the time you notice something is wrong, you have already lost nerve fibres that will never return. Treatment does not restore what is gone. It protects what remains.

The Vision You Have Now Is Not the Vision You Started With

Glaucoma removes peripheral vision first. Your central vision stays sharp until the disease is advanced. Your brain also compensates, filling in blind areas so skilfully that you do not notice them. You may have lost 30 to 40 percent of your optic nerve fibres before any symptom appears.

This is why “I can see fine” is not a safe reassurance in glaucoma. It reflects the vision that has survived, not the vision that has been lost.

Why Glaucoma Treatment Feels Unnecessary (And Why That Feeling Is Dangerous)

Glaucoma drops do not improve your vision. They do not reduce pain because glaucoma causes none. They do not change how things look today. Their only job is to lower the pressure inside your eye and slow the damage to your optic nerve.

When a treatment produces no felt benefit, stopping it feels harmless. This is the central psychological trap in glaucoma care. Patients who feel well skip doses, delay refills, or discontinue treatment altogether. The nerve continues to deteriorate. By the time symptoms appear, the loss is severe and permanent.

The absence of symptoms is not evidence that you are safe. It is evidence that the disease has not yet crossed your threshold of awareness.

What the Research Actually Shows

Studies consistently show that controlling eye pressure reduces the risk of glaucoma progression. The Ocular Hypertension Treatment Study showed that lowering pressure by 20 percent reduced conversion to glaucoma by more than half. The Early Manifest Glaucoma Trial showed that each mmHg reduction in pressure produced a measurable reduction in progression risk.

You are not treating a feeling. You are treating a measurable biological risk that happens to produce no warning before it causes irreversible harm.

“But My Pressures Are Controlled Now — Do I Still Need Drops?”

Yes. Controlled pressure means the treatment is working. Stopping treatment removes the protection. Pressure typically rises again within days to weeks after discontinuation.

Some patients assume that normal pressure readings mean the problem is resolved. Glaucoma is a chronic condition. Controlled pressure is a maintained state, not a cured one.

Normal-Tension Glaucoma: When Pressure Is Not Even the Full Story

A significant group of patients develop glaucoma with eye pressures in the statistically normal range. Their optic nerves are still vulnerable, often due to poor blood flow, structural susceptibility, or other factors. For these patients, the question “but my pressure is fine” does not mean treatment is unnecessary. It means the target pressure needs to be set lower, and other risk factors need attention.

This is one reason that glaucoma management requires individual assessment, not a one-size guideline.

FAQ

If I have no symptoms, does that mean my glaucoma is mild?

Not necessarily. Glaucoma can cause significant optic nerve damage before any symptom appears. The severity of glaucoma is assessed through structural tests like OCT and functional tests like visual fields, not through how your vision feels day to day.

What happens if I skip my glaucoma drops for a few days?

Eye pressure can rise within 24 to 48 hours of stopping treatment. Over time, this pressure exposure adds to cumulative nerve damage. Occasional missed doses are less harmful than long gaps, but no dose-skipping is risk-free in active glaucoma.

Can I know if my glaucoma is getting worse?

Progression is detected through serial OCT scans and visual field testing, not through symptoms. This is why regular follow-up is essential even when your vision feels unchanged.

My doctor wants to change my drops. Should I get a second opinion first?

A second opinion is always appropriate in glaucoma, especially if you are uncertain about treatment changes, surgical recommendations, or whether your current regimen is adequate. Glaucoma causes irreversible loss, so the cost of a wrong decision is permanent.

Are there people who do not need treatment despite a glaucoma diagnosis?

In very early suspected glaucoma or ocular hypertension with low risk factors, observation may be appropriate rather than immediate treatment. This is a clinical judgement based on your individual risk profile, your optic nerve appearance, and your visual field results. It requires an experienced glaucoma specialist to make that call correctly.

What You Should Expect From Your Glaucoma Care

A good glaucoma consultation does more than prescribe drops. It establishes your target pressure based on your stage of disease, your age, and your life expectancy. Also, it identifies your progression rate through serial testing. It reviews whether your current treatment is achieving that target. And it explains, clearly, what is at stake if treatment is inconsistent.

If you have left a consultation without understanding why your specific pressure target was chosen, that is worth asking about. If you are uncertain whether your glaucoma is stable or progressing, that is worth investigating through formal visual field and OCT trend analysis.

A Note on Seeking a Second Opinion

Glaucoma decisions carry permanent consequences. Second opinions are not a sign of distrust toward your current doctor. They are a rational response to a disease where the cost of under-treatment is irreversible. An independent review of your scans and pressure history can confirm that you are on the right path, or catch something that has been missed.

This page is part of the Glaucoma Hub hub. Read about our full approach to glaucoma care. Please also read our Second Opinion Hub. Please also read Glaucoma Diagnosis, first 90 days; and Glaucoma Treatment

Here’s another heartening patient story: Tired of drops

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google

Cataract Surgery Does Not Protect You From Glaucoma

Posted on March 7, 2026June 14, 2026 by Dr Shibal Bhartiya

Cataract surgery can improve vision by removing a cloudy lens, but it does not prevent, cure, or eliminate the risk…

Why Glaucoma May Progress Despite Treatment

Posted on March 4, 2026May 9, 2026 by Dr Shibal Bhartiya

Glaucoma may progress despite treatment if eye pressure is not low enough for that individual eye. Other factors like poor…